Current Affair Diary 18/10/2020

Thalassemia Bal Sewa Yojna

✓The second phase of “Thalassemia Bal Sewa Yojna” was recently launched for the underprivileged Thalassemic patients.

✓Launched in: 2017

✓It is a Coal India CSR funded Hematopoietic Stem Cell Transplantation (HSCT) program.

✓Aim: To provide a one-time cure opportunity for Haemoglobinopathies like Thalassaemia and Sickle Cell Disease for patients who have a matched family donor.

✓The CSR initiative was targeted to provide financial assistance to a total of 200 patients by providing a package cost not exceeding Rs. 10 lakhs per HSCT.

*Thalassemia

✓Haemoglobinopathies, such as Thalassemia and sickle cell disease are inherited disorders of red blood cells.

✓People with thalassaemia are not able to make enough haemoglobin due to which oxygen cannot get to all parts of the body.

✓Due to this, organs are unable to function properly.

✓There are two major types of thalassaemia, alpha and beta. These are named for the two protein chains that make up normal haemoglobin.

✓In India, Thalassemia Major (TM) and the severe form of Thalassemia Intermedia (TI) constitute the major burden of disease.

#GALLANT IAS

29/10/2020

0 responses on "Current Affair Diary 18/10/2020"

    Leave a Message

    Your email address will not be published. Required fields are marked *

    © Gallantias 2023 All rights reserved.